Thrombocytopenic, thromboembolic and haemorrhagic events following second dose with BNT162b2 and ChAdOx1: self-controlled case series analysis of the English national sentinel cohort

Mark Joy, Utkarsh Agrawal, Xuejuan Fan, Chris Robertson, Sneha N. Anand, Jose Ordonez-Mena, Rachel Byford, Rosalind Goudie, Gavin Jamie, Debasish Kar, John Williams, Gemma L. Marsden, Victoria Tzortziou-Brown, Sir Aziz Sheikh, F. D.Richard Hobbs, Simon de Lusignan*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Thrombocytopenic, thromboembolic and haemorrhagic events following second dose with BNT162b2 and ChAdOx1: self-controlled case series analysis of the English national sentinel cohort'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology